Faculty

Institution

Unit

Venue

Mitchell A. Avery

Professor Emeritus of Medicinal Chemistry

University of Mississippi

Affiliations

School of Pharmacy

Department of Biomolecular Sciences

Mitchell A. Avery is currently serving as a Biomolecular Sciences Professor Emeritus of Medicinal Chemistry at University of Mississippi.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Mitchell A. Avery

University of Mississippi

Professor Emeritus of Medicinal Chemistry

You can click a keyword to filter the displayed items

pharmacology medicinal chemistry chemistry organic synthesis drug discovery medicine chemical synthesis organic chemistry malaria enzyme inhibition biochemistry enzymes pharmaceutical chemistry protein science structure-activity relationships natural products natural product research clinical chemistry drug development pharmacotherapy antimalarial agent artemisinin biological evaluation clinical microbiology antiparasitic agent medicinal research drug analysis plant science rational drug design total synthesis structural molecular biology pharmaceutical sciences phytochemistry natural product synthesis molecular docking pharmacokinetics heterocyclic enantioselective synthesis pharmaceutical research protein modeling synthetic chemistry virtual screening homology modeling antimalarial activity structural chemistry applied microbiology drug targeting natural product biosynthesis protein chemistry clinical pharmacology heterocycle chemistry stereoselective synthesis comparative protein modeling plasmodium falciparum phytochemical analysis marine chemistry biomolecular structure molecular structure drug targets functional modification x-ray crystallography rat serum antimalarial artemisinin phytochemicals chemical analysis herb-drug interactions key site combinatorial chemistry experimental pharmacology crystal structures protein function molecular design structure-based virtual screening heteroatom substitution conformational analysis docking studies cunninghamella elegans

Notable Scholarly Works

Notable Federal Grants

Collaborators

Structure-Based Design of Novel Melanin-Concentrating Hormone Receptor-1 Ligands Based on Saturated Nitrogen-Containing Heterocycles. Bioorganic & Medicinal Chemistry Letters (2023)

Mohamed A. HelalAmar G. ChittiboyinaMitchell A. Avery

medicinal chemistrymedicinereceptorspharmacologypharmaceutical chemistrysaturated nitrogen-containing heterocyclesbioorganic chemistryclinical chemistrystructure-based designbiomolecular engineeringbioactive compoundsdrug discoveryhormonal receptor

Selective Inhibition of Plasmodium Falciparum Atpase 6 by Artemisinins and Identification of New Classes of Inhibitors After Expression in Yeast. Antimicrobial Agents and Chemotherapy (2022)

Catherine M. MooreJigang WangQingsong LinPedro FerreiraMitchell A. AveryKhaled ElokelyHenry M. StainesSanjeev Krishna

antimicrobial agentsmedical mycologymedicineenzyme inhibitionmicrobial pathogenesispharmacologyyeastselective inhibitionapplied microbiologyclinical microbiologybiotechnologyenzymesdrug discoveryinfectious diseasesherb-drug interactionsparasite controlantimicrobial chemotherapy

Anti‐Inflammatory Glucocorticoids. Burger's Medicinal Chemistry and Drug Discovery (2021)

Mitchell A. AveryAmar G. Chittiboyina

medicinal chemistryanti-inflammatory glucocorticoidsmedicinepharmacologydrug discoveryanti-inflammatoryinflammation

Structure–Activity Relationships of the Antimalarial Agent Artemisinin 10. Synthesis and Antimalarial Activity of Enantiomers of Rac-5β-Hydroxy-D-Secoartemisinin and Analogs: Implications Regarding the Mechanism of Action. Molecules (2021)

Mohamed JahanFrancisco LeonFrank R. FronczekKhaled M. ElokelyJohn RimoldiShabana I. KhanMitchell A. Avery

medicinal chemistrypharmacologyantimalarial activityantiparasitic agentmolecular biologystructure-activity relationshipsmalariaantimalarial agent

Isolation and Synthesis of Veranamine, an Antidepressant Lead From the Marine Sponge Verongula Rigida. Journal of Natural Products (2020)

Anna J. Kochanowska-KaramyanHugo C. AraujoXiong ZhangAbir El-AlfyPaulo CarvalhoMitchell A. AveryStephen D. HolmboJakob MagolanMark T. Hamann

medicinal chemistrynatural productsphytochemical analysisphytotherapy researchpharmacologymarine chemistrydepressionmarine biologydrug discoveryphytochemistrychemistryantidepressant leadnatural product synthesisnatural product researchphytochemicalsnatural product biosynthesis

Computationally Assisted Discovery and Assignment of a Highly Strained and Panc-1 Selective Alkaloid From Alaska’s Deep Ocean. Journal of the American Chemical Society (2019)

Yike ZouXiaojuan WangJames SimsBin WangPankaj PandeyColin L. WelshRobert P. StoneMitchell A. AveryRobert J. DoerksenDaneel FerreiraClemens AnklinFrederick A. ValerioteMichelle KellyMark T. Hamann

marine chemistrydeep oceancomputational chemistrydrug discoverychemistry

Identification of a New Small Molecule Chemotype of Melanin Concentrating Hormone Receptor-1 Antagonists Using Pharmacophore-Based Virtual Screening. Bioorganic & Medicinal Chemistry Letters (2019)

Mohamed A. HelalAmar G. ChittiboyinaMitchell A. Avery

medicinal chemistrymedicinereceptorspharmacologysmall moleculesenzyme inhibitionbioorganic chemistrydrug targetspharmacophore-based virtual screeninginhibitory activitydrug discoverymolecular biologyhormonal receptordrug targetingdrug development

A Pharmacokinetic Comparison of Homodimer Arb-92 and Heterodimer Arb-89: Novel, Potent Antimalarial Candidates Derived From 7β-Hydroxyartemisinin. Journal of Pharmaceutical Investigation (2017)

Bonnie A. AveryDeepthi PabbisettyLie LiAbhisheak SharmaMahesh K. GundluruAmar G. ChittiboyinaJohn S. WilliamsonMitchell A. Avery

pharmacologypharmacokineticspharmacokinetic comparisondrug discoverydrug development

Design, Synthesis, and Biological Evaluation of Peptidomimetic N ‐Substituted Cbz‐4‐Hyp‐Hpa‐Amides as Novel Inhibitors of Plasmodium Falciparum. Chemistry & Biodiversity (2017)

Valeriy A. BacherikovAmar G. ChittiboyinaMitchell A. Avery

medicinal chemistrymedical mycologymedicineenzyme inhibitionpharmacologypeptide scienceorganic synthesisbiological evaluationdrug discoveryantiparasitic agentnovel inhibitorschemical synthesisfunctional modificationmalariamicrobiologydrug development

Drugs for Parasitic Infections: Advances in the Discovery of New Antimalarials. Elsevier eBooks (2016)

M.A. AveryD.J. WeldonK.M. Muraleedharan

medicinepharmacologyparasitic infectionsparasitologydrug discoveryinfectious diseases

1
2
3
4
5
21
10 / page

Mitchell A. Avery

Professor Emeritus of Medicinal Chemistry

University of Mississippi

Affiliations

School of Pharmacy

Department of Biomolecular Sciences

Mitchell A. Avery is currently serving as a Biomolecular Sciences Professor Emeritus of Medicinal Chemistry at University of Mississippi.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Mitchell A. Avery

University of Mississippi

Professor Emeritus of Medicinal Chemistry

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Structure-Based Design of Novel Melanin-Concentrating Hormone Receptor-1 Ligands Based on Saturated Nitrogen-Containing Heterocycles. Bioorganic & Medicinal Chemistry Letters (2023)

Mohamed A. HelalAmar G. ChittiboyinaMitchell A. Avery

Selective Inhibition of Plasmodium Falciparum Atpase 6 by Artemisinins and Identification of New Classes of Inhibitors After Expression in Yeast. Antimicrobial Agents and Chemotherapy (2022)

Catherine M. MooreJigang WangQingsong LinPedro FerreiraMitchell A. AveryKhaled ElokelyHenry M. StainesSanjeev Krishna

Anti‐Inflammatory Glucocorticoids. Burger's Medicinal Chemistry and Drug Discovery (2021)

Mitchell A. AveryAmar G. Chittiboyina

medicinal chemistryanti-inflammatory glucocorticoidsmedicinepharmacologydrug discoveryanti-inflammatoryinflammation

Mohamed JahanFrancisco LeonFrank R. FronczekKhaled M. ElokelyJohn RimoldiShabana I. KhanMitchell A. Avery

medicinal chemistrypharmacologyantimalarial activityantiparasitic agentmolecular biologystructure-activity relationshipsmalariaantimalarial agent

Isolation and Synthesis of Veranamine, an Antidepressant Lead From the Marine Sponge Verongula Rigida. Journal of Natural Products (2020)

Anna J. Kochanowska-KaramyanHugo C. AraujoXiong ZhangAbir El-AlfyPaulo CarvalhoMitchell A. AveryStephen D. HolmboJakob MagolanMark T. Hamann

Computationally Assisted Discovery and Assignment of a Highly Strained and Panc-1 Selective Alkaloid From Alaska’s Deep Ocean. Journal of the American Chemical Society (2019)

Yike ZouXiaojuan WangJames SimsBin WangPankaj PandeyColin L. WelshRobert P. StoneMitchell A. AveryRobert J. DoerksenDaneel FerreiraClemens AnklinFrederick A. ValerioteMichelle KellyMark T. Hamann

marine chemistrydeep oceancomputational chemistrydrug discoverychemistry

Identification of a New Small Molecule Chemotype of Melanin Concentrating Hormone Receptor-1 Antagonists Using Pharmacophore-Based Virtual Screening. Bioorganic & Medicinal Chemistry Letters (2019)

Mohamed A. HelalAmar G. ChittiboyinaMitchell A. Avery

A Pharmacokinetic Comparison of Homodimer Arb-92 and Heterodimer Arb-89: Novel, Potent Antimalarial Candidates Derived From 7β-Hydroxyartemisinin. Journal of Pharmaceutical Investigation (2017)

Bonnie A. AveryDeepthi PabbisettyLie LiAbhisheak SharmaMahesh K. GundluruAmar G. ChittiboyinaJohn S. WilliamsonMitchell A. Avery

pharmacologypharmacokineticspharmacokinetic comparisondrug discoverydrug development

Design, Synthesis, and Biological Evaluation of Peptidomimetic N ‐Substituted Cbz‐4‐Hyp‐Hpa‐Amides as Novel Inhibitors of Plasmodium Falciparum. Chemistry & Biodiversity (2017)

Valeriy A. BacherikovAmar G. ChittiboyinaMitchell A. Avery

Drugs for Parasitic Infections: Advances in the Discovery of New Antimalarials. Elsevier eBooks (2016)

M.A. AveryD.J. WeldonK.M. Muraleedharan

medicinepharmacologyparasitic infectionsparasitologydrug discoveryinfectious diseases

1
2
3
4
5
21
10 / page

Similar Faculty Members

Michael E Johnson

Institution

University of Illinois Chicago

molecular biology

biomolecular engineering

Hendrik Luesch

Institution

University of Florida

marine cyanobacteria

natural product biosynthesis

Stephen Hanessian

Institution

University of California, Irvine

organic chemistry

medicinal chemistry

Yan Zhang

Institution

Virginia Commonwealth University

psychoactive substance use

world psychiatry

Jon Thorson

Institution

University of Kentucky

biochemistry

molecular biology

Paul R. Carlier

Institution

University of Illinois Chicago

infectious diseases (medical specialty)

malaria

Charles E. McKenna

Institution

University of Southern California

future medicinal chemistry

medicinal chemistry

Richard B. Silverman

Institution

Northwestern University

pharmacology

medicinal chemistry

Scott G. Franzblau

Institution

University of Illinois Chicago

antibiotic

tuberculosis

Chang-Guo Zhan

Institution

University of Kentucky

future medicinal chemistry

molecular docking

Similar Faculty Members

Michael E Johnson

Institution

University of Illinois Chicago

molecular biology

biomolecular engineering

Hendrik Luesch

Institution

University of Florida

marine cyanobacteria

natural product biosynthesis

Stephen Hanessian

Institution

University of California, Irvine

organic chemistry

medicinal chemistry

Yan Zhang

Institution

Virginia Commonwealth University

psychoactive substance use

world psychiatry

Jon Thorson

Institution

University of Kentucky

biochemistry

molecular biology

Paul R. Carlier

Institution

University of Illinois Chicago

infectious diseases (medical specialty)

malaria

Charles E. McKenna

Institution

University of Southern California

future medicinal chemistry

medicinal chemistry

Richard B. Silverman

Institution

Northwestern University

pharmacology

medicinal chemistry

Scott G. Franzblau

Institution

University of Illinois Chicago

antibiotic

tuberculosis

Chang-Guo Zhan

Institution

University of Kentucky

future medicinal chemistry

molecular docking